Executive Director, Global Facilities Operations at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Strategic leadership experience in global facilities operations across multiple sites in North America, UK, Belgium, and Switzerland
Ability to lead a highly motivated GFO Leadership Team in a matrixed organization
Expertise in coordinating with Global Capital Services and Solutions (CSS), Corporate EHSS, Business Development, Operational Excellence, and other Enabling Business Partners
Experience developing, delivering, and governing a global Integrated Facilities Management (IFM) service delivery model
Financial management skills for a $700M+ OpEx P&L and developing long-term CapEx strategic plans based on asset life cycle management
Capability to create innovative programs for attracting, developing, and retaining future GTS Leaders
Knowledge of sustainability programs and advancing them across a global footprint

Responsibilities

Provide strategic leadership for the Global Facilities Operations (GFO) Team overseeing R&D, Product Development, Corporate Headquarters, and Commercial offices
Deliver safe, effective, and strategically aligned Facilities Services to meet key stakeholder needs, emphasizing continuous performance optimization, technology adoption, and exceptional user experience
Develop strategic Facilities Services for 22 locations in North America, UK, and Europe
Build a vision for organizational culture through amenities and services delivered to site occupants
Support senior leadership in strategies for accommodating growth and a dynamic office/research landscape for R&D, GDD, PD, GPDO, GPS, and Enabling Functions
Collaborate with Global CSS and Corporate Real Estate/Workplace Services on future space requirements, site/regional Master Planning, optimizing square footage, site divestitures, and new business development integrations
Champion innovative digital tools and technologies for operational excellence in Facilities Services delivery, management, and monitoring
Implement Sustainability programs across the global footprint in partnership with Corporate EHSS to support company goals
With the GFO Leadership Team, develop [incomplete in description]

Skills

Facilities Management

Strategic Leadership

Global Operations

Sustainability

EHSS

Technology Adoption

Stakeholder Management

Performance Optimization

Matrixed Organizations

R&D Facilities

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free